Altimmune Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Altimmune, Inc. (ALT) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
Current Assets
Cash and Cash Equivalents36.93135.12184.88190.30215.9237.27
Short-Term Investments94.9762.7073.780.00100.010.00
Cash & Short-Term Investments131.89197.82184.88190.30215.9237.27
Accounts Receivable0.544.850.170.434.611.65
Inventory0.000.000.000.000.000.00
Other Current Assets2.206.920.710.247.76-0.03
Total Current Assets137.25209.63192.81198.72230.2639.39
Non-Current Assets
Property, Plant & Equipment (Net)0.411.011.081.451.061.80
Intangible Assets0.000.0012.4212.4212.820.00
Other Non-Current Assets1.644.112.986.280.980.13
Total Non-Current Assets2.054.7616.4820.1514.8614.66
Total Assets139.31210.64206.93218.87245.1254.06
Current Liabilities
Accounts Payable0.212.074.802.030.610.02
Short-Term Debt0.280.000.000.000.000.00
Accrued Liabilities9.989.5810.639.7411.050.00
Other Current Liabilities9.9810.0712.2516.2411.413.90
Total Current Liabilities10.4712.1417.0518.2812.023.92
Non-Current Liabilities
Long-Term Debt1.400.184.581.451.831.86
Other Non-Current Liabilities3.934.060.066.095.392.75
Total Non-Current Liabilities5.334.404.581.457.224.61
Total Liabilities15.8016.5421.6419.7319.248.54
Stockholders' Equity
Common Stock0.010.010.010.000.000.00
Retained Earnings-561.39-466.33-383.11-298.21-191.47-137.38
Accumulated Other Comprehensive Income-4.97-5.00-5.23-5.04-5.04-5.02
Additional Paid-in Capital689.86665.43568.40497.34417.34187.91
Shares Outstanding72.3570.6849.2040.990.000.00
Total Stockholders' Equity123.51194.10185.29199.14225.8845.52
Total Liabilities & Equity139.31210.64206.93218.87245.1254.06